(Q34726899)

4 August 2017

Predicting the risk for dialysis or death in IgA nephropathy (English)

1 reference

4 August 2017

0 references

François Berthoux

1

1 reference

4 August 2017

Hesham Mohey

2

1 reference

4 August 2017

Blandine Laurent

3

1 reference

4 August 2017

Christophe Mariat

4

1 reference

4 August 2017

Aida Afiani

5

1 reference

4 August 2017

Lise Thibaudin

6

1 reference

4 August 2017

21 January 2011

1 reference

Journal of the American Society of Nephrology

4 August 2017

1 reference

4 August 2017

22

1 reference

4 August 2017

4

1 reference

4 August 2017

752-761

1 reference

Histopathologic features aid in predicting risk for progression of IgA nephropathy

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Prehypertension: epidemiology, consequences and treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Efficacy and safety of glucocorticoids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Risk stratification for progression of IgA nephropathy using a decision tree induction algorithm

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Testing for causality and prognosis: etiological and prognostic models

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Natural history of primary IgA nephropathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Use and misuse of the receiver operating characteristic curve in risk prediction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Predicting progression in IgA nephropathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Predicting renal outcome in IgA nephropathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

[Intercapillary deposits of IgA-IgG]

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Comparison of pathological lesions on repeated renal biopsies in 73 patients with primary IgA glomerulonephritis: value of quantitative scoring and approach to final prognosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

A general cardiovascular risk profile: The Framingham study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Errors induced by indexing glomerular filtration rate for body surface area: reductio ad absurdum.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

CC-chemokine receptor five gene polymorphism in primary IgA nephropathy: the 32 bp deletion allele is associated with late progression to end-stage renal failure with dialysis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Prognostic indicators of IgA nephropathy in the Chinese--clinical and pathological perspectives

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065230

Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy

26 October 2018

1 reference

12 December 2020

Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up

1 reference

12 December 2020

Predicting prognosis in IgA nephropathy

1 reference

12 December 2020

1 reference

12 December 2020

IgA glomerular deposits in renal disease

1 reference

12 December 2020

Toward individual prognosis of IgA nephropathy

1 reference

12 December 2020

Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses

1 reference

12 December 2020

Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases

1 reference

12 December 2020

The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group

1 reference

12 December 2020

The chemokine receptor 5 Delta32 mutation is associated with increased renal survival in patients with IgA nephropathy

1 reference

12 December 2020

1 reference

12 December 2020

A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study

1 reference

12 December 2020

Remission of proteinuria improves prognosis in IgA nephropathy

1 reference

12 December 2020

Validation of the Toronto formula to predict progression in IgA nephropathy

1 reference

12 December 2020

Identifiers

DOI

10.1681/ASN.2010040355

1 reference

4 August 2017

1 reference

4 August 2017

1 reference